Raiffeisen Bank International AG Cuts Stake in HCA Healthcare, Inc. $HCA

Raiffeisen Bank International AG trimmed its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 28.1% in the second quarter, according to the company in its most recent filing with the SEC. The fund owned 10,251 shares of the company’s stock after selling 4,011 shares during the quarter. Raiffeisen Bank International AG’s holdings in HCA Healthcare were worth $4,022,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. BlackRock Inc. purchased a new stake in HCA Healthcare during the second quarter valued at about $5,069,974,000. Norges Bank bought a new stake in shares of HCA Healthcare in the 4th quarter valued at about $1,262,513,000. Legal & General Group Plc bought a new position in HCA Healthcare during the 2nd quarter worth approximately $410,992,000. Jupiter Topco LLC bought a new stake in HCA Healthcare in the second quarter valued at approximately $371,138,000. Finally, Life Cycle Investment Partners Ltd bought a new position in shares of HCA Healthcare in the fourth quarter worth approximately $374,037,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Analyst Ratings Changes

HCA has been the subject of several analyst reports. Weiss Ratings cut shares of HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday, June 9th. Royal Bank Of Canada reiterated an “outperform” rating and set a $435.00 target price on shares of HCA Healthcare in a report on Monday, July 27th. Sanford C. Bernstein restated a “market perform” rating on shares of HCA Healthcare in a report on Wednesday, July 15th. Morgan Stanley cut their price objective on HCA Healthcare from $425.00 to $380.00 and set an “underweight” rating on the stock in a research report on Monday, July 27th. Finally, Truist Financial decreased their target price on HCA Healthcare from $535.00 to $495.00 and set a “buy” rating for the company in a report on Monday, July 27th. Fourteen research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $462.64.

HCA Healthcare Price Performance

Shares of HCA opened at $404.95 on Friday. HCA Healthcare, Inc. has a one year low of $353.99 and a one year high of $556.52. The company has a 50-day simple moving average of $403.35 and a two-hundred day simple moving average of $437.55. The firm has a market capitalization of $87.67 billion, a PE ratio of 13.56, a price-to-earnings-growth ratio of 1.35 and a beta of 1.10.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.56 by $0.03. The firm had revenue of $20.23 billion during the quarter, compared to analyst estimates of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The business’s revenue was up 8.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $6.84 EPS. Analysts expect that HCA Healthcare, Inc. will post 29.42 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be issued a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Wednesday, September 16th. HCA Healthcare’s payout ratio is 10.45%.

HCA Healthcare Profile

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.